Where Capital Flows
Investors favor:
- AI-powered platforms
- Value-based care tools
- Female health (menopause, hormones)
Valuation Benchmarks:
- 4–6x revenue for most healthtech
- 6–8x for AI/diagnostics
- 10–14x EV/EBITDA for EBITDA-positive firms
Learn more at Scaling MedTech: From Product to Market
This post is part of SaMD Europe Launch Guide.
This content has been enhanced by GenAI tools.